JTI Innovative Medicines Initiative 2 launches call 7 and 8
IMI has launched its 7th and 8th Calls under IMI 2 on 18 December 2015. The IMI2 7th call for proposals - H2020-JTI-IMI2-2015-07-TWO-STAGE- has a budget of € 93,604,000. The closing date for applications is March 17, 2016. The IMI2 8TH call for proposals - H2020-JTI-IMI2-2015-08-SINGLE-STAGE- has a budget of € 70,000,000. 1st cut-off date: March 16, 2016. Next cut-off dates: 15 September 2016, 16 March 2017, 14 September 2017 and 15 March 2018.
From 11 to 29 January 2016, IMI will hold webinars on each topic of the upcoming IMI2 7th and 8th Calls for proposals, as well as one webinar on the IMI2 rules and procedures. Registration for the webinars is free but obligatory. For more information and Webinar schedule please click here.
IMI 2 - Call 7 includes topics on safety, neurological disorders, pain, eye diseases, cancer, and big data. IMI 2 - Call 8 is an open Call on Ebola & related diseases.
The goal of the IMI 2 programme is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI's first phase. As before, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.